Latest Gluten-free diet Stories
NEW YORK, Sept. 22 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. U.S. Market for Whole and Other Grains: Trends and Developments, The http://www.reportlinker.com/p0116175/US-Market-for-Whole-and-Other-Grains-Trends-and-Developments-The.html After years of falling consumption, grains are back on the menu, with per capita use rising. Wheat, rice, oats, barley and a host of specialty grains are regaining acceptance from consumers,...
NEW YORK, Sept. 22 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Gluten-Free Food and Beverage Market: Trends and Developments Worldwide, 2nd Edition, The http://www.reportlinker.com/p0116172/Gluten-Free-Food-and-Beverage-Market-Trends-and-Developments-Worldwide-2nd-Edition-The.html The retail market for gluten-free foods and beverages is exploding as a result of multiple triggers. On the marketer side, giant General Mills has...
SAN DIEGO, June 29 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the launch of MyCeliacID(TM), the first do it yourself, saliva-based genetic test dedicated to celiac disease. MyCeliacID identifies distinct genetic sequences associated with celiac disease, a largely undiagnosed genetic disorder that affects approximately 3 million people in the United States. MyCeliacID is the saliva-based version of a blood test used by...
ORLANDO, Fla., May 20 /PRNewswire/ -- Chia Seed Flour is the buzz when it comes to gluten-free baking and alternatives to highly processed wheat flour. Chia Seed Flour is made from the tiny chia seeds. The chia seed was the super food of the Aztec warriors. It is the most nutritious grain available today. Now, thanks to some clever nutritionist and Nuchia Foods Corporation, Chia Seed Flour is once again available for dinner tables everywhere. It is an excellent source of omega-3 and...
Argentinean-based company now offers their great-tasting, all-natural nutrition bars for the first time in the U.S. DELRAY BEACH, Fla., April 20 /PRNewswire/ -- NatureCrops, the nutrition bars based on the ancient grain quinoa and other natural ingredients, selects TransMedia Group as their public relations agency of record. NatureCrops was developed by AMS foods in Argentina, which is currently marketing the nutrition bars all over the globe, and now for the first time in the U.S....
ORLAND PARK, Ill., Feb. 19 /PRNewswire/ -- Whether it is due to allergies, gluten intolerance, autism, or diabetes, many now turn to special diets that eliminate ingredients such as gluten or milk. Likewise, with asthma and environmental allergies on the rise, many seek relief by using air purifiers and non-toxic cleaning, health and beauty products. A father of two daughters with multiple food and environmental allergies wanted to do something that would make life easier for...
One in 133 people suffer from celiac disease ANN ARBOR, Mich., Feb. 2 /PRNewswire-USNewswire/ -- Dorothy Carpenter had stomach problems her entire life. Eating as much as a bite of bread or pasta could lead to terrible pain. Her illness went undiagnosed for years until a University of Michigan Health System physician recognized it as celiac disease. By then her long-standing condition had become an intestinal mass, a cancer that forced doctors to remove part of her small intestine. "I've...
Whole Foods Market Inc. has pulled three gluten-free products for children because the items actually contain the substance, the Texas grocery chain said. The chain, with 273 U.S. stores, also said it would create a strict gluten-free definition and begin monitoring its items so such problems don't recur. Three products made for Whole Foods by Wellshire Farms Inc. of Swedesboro, N.J. -- Chicken Bites Dinosaur Shaped, chicken corn dogs and beef corn dogs -- contained between 116 and 2,200...
Alba Therapeutics, a clinical-stage biopharmaceutical company, has announced that for the first time, a European patient with active celiac disease has been enrolled in its clinical trial to investigate a treatment for the disease. Alba has enrolled and randomized the newly diagnosed patient from Spain in an eight-week Phase IIb trial with oral larazotide acetate, a tight junction regulator, for the treatment of patients with active celiac disease (CD). The global multi-center, randomized,...
BALTIMORE, Nov. 11 /PRNewswire/ -- Alba Therapeutics Corporation announced today that for the first time, a European patient with active celiac disease has been enrolled in its clinical trial to investigate a treatment for the disease. Alba has enrolled and randomized the newly diagnosed patient from Spain in an eight-week Phase IIb trial with oral larazotide acetate, a tight junction regulator, for the treatment of patients with active celiac disease (CD). The global multi-center,...
